Alberta Investment Management Corp Purchases New Position in Teleflex Incorporated (NYSE:TFX)

Alberta Investment Management Corp acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX) in the fourth quarter, HoldingsChannel.com reports. The institutional investor acquired 11,300 shares of the medical technology company’s stock, valued at approximately $2,011,000.

Several other large investors have also recently bought and sold shares of the company. Cromwell Holdings LLC grew its holdings in shares of Teleflex by 59.0% in the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock valued at $33,000 after buying an additional 49 shares during the period. Apollon Wealth Management LLC increased its position in shares of Teleflex by 3.7% during the third quarter. Apollon Wealth Management LLC now owns 1,524 shares of the medical technology company’s stock worth $377,000 after acquiring an additional 55 shares in the last quarter. SRS Capital Advisors Inc. increased its holdings in Teleflex by 0.3% during the 3rd quarter. SRS Capital Advisors Inc. now owns 19,587 shares of the medical technology company’s stock worth $4,844,000 after purchasing an additional 60 shares in the last quarter. Janney Montgomery Scott LLC raised its position in Teleflex by 0.4% in the 3rd quarter. Janney Montgomery Scott LLC now owns 15,332 shares of the medical technology company’s stock valued at $3,792,000 after buying an additional 65 shares during the last quarter. Finally, Tokio Marine Asset Management Co. Ltd. raised its holdings in shares of Teleflex by 4.5% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,517 shares of the medical technology company’s stock valued at $375,000 after purchasing an additional 66 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Price Performance

Teleflex stock opened at $175.43 on Friday. The company has a market capitalization of $8.15 billion, a price-to-earnings ratio of 34.88, a PEG ratio of 1.73 and a beta of 1.16. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12 month low of $165.62 and a 12 month high of $249.90. The stock’s 50 day moving average is $177.07 and its 200-day moving average is $207.80.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on TFX. Mizuho lowered their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. Royal Bank of Canada dropped their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Finally, Truist Financial dropped their price target on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Three equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Teleflex has an average rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.